Icon

GEODON (nda020825)- (EQ 20MG BASE,EQ 40MG BASE,EQ 60MG BASE,EQ 80MG BASE)

ZIPRASIDONE HYDROCHLORIDE VIATRIS
EQ 20MG BASE,EQ 40MG BASE,EQ 60MG BASE,EQ 80MG BASE
Yes No
2019-May-27 Expired
None None
None No
GEODON is indicated as an oral formulation for the: Treatment of schizophrenia, Acute treatment as monotherapy of manic or mixed episodes associated with bipolar I disorder, Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate,
8 0 8
Total Other Developers None
Drugs with Suitability No
EQ 20MG BASE ** ** - 6 1
EQ 40MG BASE ** ** - - 7
EQ 60MG BASE ** ** - 6 1
EQ 80MG BASE ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ***** ****** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ***** ****** ***** ******* *********** ****-*, **** **. ***, ***, ****** - **, ******* ******** ****, *****, ******, *********** ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** **-**, ****** ** *** ******* ********** ****** ********, *****, ***** ******, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ****** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.